Study of Cardiovascular Risk Factors and Hemostatic Molecular Markers in Elderly Persons

ABSTRACT

In this study, plasma concentrations of hemostatic molecular markers were investigated in 118 elderly persons with normal renal function (aged 65 to 97 years) who could manage their activities of daily living (ADL) by themselves, to find a strategy for conservation or elevation of ADL and quality of life (QOL). In all subjects, the frequency by which hemostatic markers exceeded their upper limit of normal range was 35.9% for thrombin-antithrombin III complex (≥3.7 ng/ml), 38.3% for soluble fibrin monomer (≥4.0 μg/ml), 41.8% for D-dimer (≥1.0 μg/ml), 49.0% for plasmin-α₂ plasmin inhibitor complex (≥1.0 μg/ml), and 53.7% for thrombomodulin (≥20 ng/ml). The mean plasma levels of these markers were slightly higher than the upper limit of their normal range. These markers were also investigated in samples of patients with and without cardiovascular risk factors and with and without cardiovascular diseases (ischemic heart disease and/or cerebral infarction). Furthermore, the results were analyzed in relationships between cardiovascular disease and cardiovascular risk factor or aging. The findings suggest that aging exerts a stronger influence on plasma levels of these hemostatic molecular markers than the presence of cardiovascular risk factors and cardiovascular diseases. From the viewpoint for conservation or elevation of ADL and QOL in elderly persons, also other factor, such as drug intake, lifestyle, aging, and so on, must be considered to clarify the relationship between the plasma levels of the hemostatic molecular markers and cardiovascular risk factors or cardiovascular diseases.

KEYWORD

Elderly - hemostatic molecular markers - cardiovascular risk factors - cardiovascular diseases

REFERENCES

• 1 Kario K, Matsuo T, Kobayashi H. Which factors affect high D-dimer levels in the elderly?.  Thromb Res . 1991;  62 501-508
• 2 Deguchi A, Deguchi K, Shimura M. Spa bathing activates fibrinolysis in patients with cerebral infarction.  Intern Med . 1993;  32 619-622
• 3 Deguchi A, Ohnishi K, Nakagawa H. Lipoprotein(a) and effective renal plasma flow rate in older patients with arteriosclerotic diseases.  JAGS . 1995;  43 1067-1068
• 4 Deguchi K, Izumi K, Noguchi M, Wada H, Shirakawa S. Response of the cubital vein to occlusion and calcification of the abdominal aorta in patients with chronic renal failure on maintenance hemodialysis.  Thromb Res . 1988;  49 69-77
• 5 Deguchi K, Izumi K, Noguchi M. Coagulation and fibrinolysis in patients with chronic renal failure on maintenance hemodialysis.  Acta Haematol Jpn . 1989;  52 140-146
• 6 Cushman M, Psaty B M, Macy E. Correlates of thrombin markers in an elderly cohort free of clinical cardiovascular disease.  Arterioscler Thromb Vasc Biol . 1996;  16 1163-1169
• 7 DeSouza C A, Jones P P, Seals D R. Physical activity status and adverse age-related differences in coagulation and fibrinolytic factors in women.  Arterioscler Thromb Vasc Biol . 1998;  18 362-368
• 8 Deguchi K, Noguchi M, Iwasaki E. Dynamic fluctuations in blood of thrombin/antithrombin III complex (TAT).  Am J Hematol . 1991;  38 86-89
• 9 Deguchi K, Tsukada T, Oonishi K, Murashima S, Nishikawa M. Study on hyperactivated state of coagulation and fibrinolysis. In: Shen M-C, Teng C-M, Takada A, eds. Current Aspects of Blood Coagulation, Fibrinolysis and Platelets Tokyo: Springer-Verlag, 1993: 93-97
• 10 Deguchi A, Ohnishi K, Nakamura S. Plasma thrombomodulin values and hepatorenal function in the elderly.  Arch Gerontol Geriatr . 1997;  24 47-54
• 11 Kapiotis S, Jilma B, Quehenberger P. Morning hypercoagulability and hypofibrinolysis. Diurnal variations in circulating activated factor VII, prothrombin fragment F1+2, and plasmin-plasmin inhibitor complex.  Circulation . 1997;  96 19-21
• 12 Mari D, Mannucci P M, Coppola R. Hypercoagulability in centenarians: the paradox of successful aging.  Blood . 1995;  85 3144-3149
• 13 Bijnen F CH, Feskens E JM, Giampaoli S. Haemostatic parameters and lifestyle factors in elderly men in Italy and The Netherlands.  Thromb Haemost . 1996;  76 411-416